Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Biopharmaceutics and Pharmacokinetics: Overview

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...

Bioequivalence: Overview

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

French translation and adaptation of the KDIGO nomenclature for kidney function and disease

Nephrologie & therapeutique·2025

Same author

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.

Dermatology and therapy·2023

Same author

Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis.

Journal of drugs in dermatology : JDD·2022

Same author

Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update.

Journal of cutaneous medicine and surgery·2022

Same author

The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases.

Advances in therapy·2022

Same author

Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paper.

Dermatologic therapy·2022

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

Practical aspects of prescribing a biologic.

Yves Poulin¹, Marc Bourcier

¹Hôpital Hôtel-Dieu de Québec, Quebec City, QC. poulinyves@videotron.ca

Journal of Cutaneous Medicine and Surgery

|October 6, 2009

Summary

Prescribing biologic agents for psoriasis requires careful patient assessment before treatment, including necessary laboratory tests and contraindications. Ongoing monitoring is crucial for the safe and effective use of these advanced psoriasis treatments.

Area of Science:

Dermatology
Immunology
Pharmacology

Background:

Biologic agents are increasingly utilized for psoriasis management.
Psoriasis treatment with biologics necessitates specialized knowledge for practitioners.

Purpose of the Study:

To outline essential clinical and laboratory assessments prior to initiating biologic therapy for psoriasis.
To identify contraindications for biologic treatment in potential psoriasis candidates.
To discuss critical monitoring parameters for safe and effective biologic use in psoriasis patients.

Main Methods:

Review of current clinical guidelines and literature on biologic therapy for psoriasis.
Description of pre-treatment evaluation protocols.
Discussion of post-treatment monitoring strategies.

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Related Experiment Videos

Last Updated: Jun 19, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Main Results:

Pre-treatment assessments include specific laboratory tests and evaluation for contraindications.
Monitoring involves regular clinical assessments and targeted laboratory investigations.
Identification of key safety considerations for long-term biologic use.

Conclusions:

Comprehensive pre-treatment evaluation and vigilant monitoring are vital for optimizing biologic therapy outcomes in psoriasis.
Awareness of contraindications and unique procedural requirements ensures patient safety.
Effective management of psoriasis with biologics relies on a thorough understanding of these agents.